Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Feb 7, 2020 (7 years ago)

Amoxicillin and Clavulanate Potassium Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Foreign Substance: Customer complaint of a foreign substance identified as nylon cable tie

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Amoxicillin and Clavulanate Potassium Tablets, USP, 875 mg/125 mg, 20-count bottles, Distributed by: Aurobindo Pharma USA. Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India; NDC 65862-503-20

Affected NDC 65862-0503-20

Compare with the code on your package — it is the most precise check available.

Drug: Amoxicillin Category: Antibiotic

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Amoxicillin and Clavulanate Potassium
NDC 65862-0503
AMOXICILLIN 875 mg/1; CLAVULANATE POTASSIUM 125 mg/1 Tablet, Film Coated Aurobindo Pharma Limited DRUG FOR FURTHER PROCESSING
Recalling firm
AuroMedics Pharma LLC
NDC code
65862-503-20
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0852-2020 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Amoxicillin recalls

See all
Class II · Moderate risk

Amoxicillin Capsules

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0781-2613-01 D-1025-2022
Class II · Moderate risk

AMOXICILLIN Tablets

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Terminated Temperature excursion Cardinal Healthcare D-0166-2024

Other recalls by AuroMedics Pharma LLC

All 2020 recalls
Class II · Moderate risk

Acyclovir Sodium Injection

Presence of Particulate Matter: Customer complaint for a dark red, brown and black particulate floating inside vial.

Completed Particulate / foreign matter AuroMedics Pharma LLC NDC 55150-154-10 D-0013-2023